You Position: Home > Paper

Evaluation of coronary heart disease risks in patients with psoriasis

( views:714, downloads:144 )
Author:
No author available
Journal Title:
Chinese Journal of Dermatology
Issue:
9
DOI:
10.3760/cma.j.issn.0412-4030.2012.09.005
Key Word:
银屑病;冠状动脉疾病;危险性评估;Psoriasis;Coronary disease;Risk assessment

Abstract: Objective To estimate the 10-year risk of coronary heart disease in patients with psoriasis,and to determine whether the risk profile is affected by disease duration,family history and clinical types of psoriasis.Methods Data were pooled from 322 inpatients with psoriasis and 297 inpatients with other skin diseases (151 cases of acute urticaria,33 drug eruption,113 herpes zoster) from December 2008 to December 2010 in the Department of Dermatology,West China Hospital of Sichuan University.Risks of coronary heart disease were estimated by using the Framingham risk score algorithm.Wilcoxon rank test,Kruskal-Wallis test and chi-square tests were used to evaluate the differences in risks and risk factors between the patients with psoriasis and controls.Results As far as the Framingham 10-year risk score was concerned,the difference was statistically significant between the patients with psoriasis and the control population (6% vs.4%,Z =4.342,P =0.000),as well as between patients with different clinical types of psoriasis (6% for psoriasis vulgaris vs.4% for pustular psoriasis vs.7% for psoriasis arthropathica vs.7% for erythroderma psoriaticum,H =8.484,P < 0.05),but was insignificant between patients with familial and sporadic psoriasis (6% vs.6%,Z =0.406,P > 0.05 ).No correlation was observed between the Framingham 10-year risk and psoriasis duration (P > 0.05 ).Conclusions Increased risks of coronary heart disease exist in patients with psoriasis compared with those with acute urticaria,drug eruption or hepers zoster,and in patients with psoriasis arthropathica or erythroderma psoriaticum compared with those with pustular psoriasis.The Framingham 10-year risk of coronary heart disease is uncorrelated with disease duration and unaffected by family history of psoriasis.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn